Current oral B12 supplements either rely on passive diffusion, which is often inadequate for IF-deficient patients, or use porcine-derived intrinsic factor, which can trigger immune responses and has not been systematically optimised for therapeutic use
10.1016/j.freeradbiomed.2013.11.014 43 FengH.SchorppK.JinJ.YozwiakC
vagy a BMI-je legalbb 27 kg/m, s fennll legalbb egy, testsllyal sszefgg trsbetegsg
That said , the study provides useful reassurance about the safety of this class of drugs
JH: Writing original draft
The efficacy of semaglutide in controlling blood glucose levels and facilitating weight loss, along with the cardiovascular benefits demonstrated in the SUSTAIN-6 and PIONEER-6 trials, has expanded its clinical utility, potentially making it a first-line choice for many patients